# Waylis Therapeutics – FDA Inspection, Feb 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/waylis-therapeutics/9556879f-5f81-4433-881b-59a74b649726
Source feed: FDA_Inspections

> FDA inspection 1303428 of Waylis Therapeutics, February 12, 2026. 1 citation under 21 CFR part 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303428
- Company Name: Waylis Therapeutics
- Inspection Date: 2026-02-12
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)

Company: https://www.keypedia.com/companies/waylis-therapeutics/3d1c452a-fef8-4404-a314-dc9fb6038b9b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
